A novel (S)-(+)-decursin derivative reduced ovalbumin-specific immunoglobulin E (IgE) levels in an OVA-induced mouse model of asthma and alleviated lung inflammation in mice, and thus might be an effective therapeutic agent for allergic airway diseases (Yang et al., 2009). This evidence concerns the gene IGHE and asthma.